R A Cukingnan
Overview
Explore the profile of R A Cukingnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
CAREY J, Cukingnan R, Singer L
Ann Thorac Surg
. 1995 Jan;
59(1):112-7.
PMID: 7818310
We followed up 1,335 patients (287 female, 1,048 male) for 2 to 18 years (mean, 4.3 years) after they had undergone coronary artery bypass grafting. A health status index was...
2.
CAREY J, Cukingnan R, Singer L
J Thorac Cardiovasc Surg
. 1992 Jan;
103(1):108-15.
PMID: 1728695
The effect of increasing age on quality of life, survival, and risk of reoperation was studied in 2479 patients followed up prospectively 2 to 20 years after myocardial revascularization. Quality...
3.
CAREY J, Cukingnan R, Carson E
Am Surg
. 1991 Dec;
57(12):830-5.
PMID: 1746804
The Paul Gann Blood Safety Act became law in California on January 1, 1990, mandating that patients be informed of the risks and alternatives of blood transfusions. To evaluate the...
4.
CAREY J, Cukingnan R, EUGENE J
Clin Cardiol
. 1989 Mar;
12(3):157-60.
PMID: 2647328
Myocardial rupture is found in approximately 20% of fatal infarctions, but the diagnosis is rarely made before death. Rupture occurs in "expanding" transmural infarctions. The diagnosis should be considered in...
5.
Brown B, Cukingnan R, Derouen T, Goede L, Wong M, Fee H, et al.
Circulation
. 1985 Jul;
72(1):138-46.
PMID: 3874009
One hundred forty-seven consecutive coronary bypass patients were enrolled in a randomized, double-blind, risk-stratified, placebo-controlled prospective trial evaluating the effect on graft patency of 325 mg tid aspirin (ASA) plus...
6.
Roth J, Golub S, Cukingnan R, Brazier J, Morton D
Ann Thorac Surg
. 1981 Apr;
31(4):350-6.
PMID: 7011230
Sequential in vitro lymphocyte function tests in 13 patients undergoing cardiac operation were performed to determine factors that contribute to depressed cell-mediated immunity following operation. Lymphocytes were stimulated with phytohemagglutinin...
7.
Cukingnan R, CAREY J, Wittig J, Brown B
J Thorac Cardiovasc Surg
. 1980 Feb;
79(2):188-93.
PMID: 7351843
No abstract available.
8.
CAREY J, Cukingnan R, Groner G
Circulation
. 1979 Aug;
60(2 Pt 2):30-3.
PMID: 376179
Wadsworth Veterans Administration Hospital (VA-W) dropped out of the VA Coronary Cooperative Study (VA-Coop) in 1971 because of difficulty adhering to selection criteria, and because of the lack of standardization...
9.
Roth J, Cukingnan R, Brown B, Gocka E, CAREY J
Ann Thorac Surg
. 1979 Aug;
28(2):176-83.
PMID: 314277
To determine factors affecting saphenous vein graft patency, 218 grafts in 66 unselected patients were studied angiographically 1 year after operation. Fourteen variables were extracted from the angiograms, electrocardiograms, and...
10.
Roth J, Cukingnan R, Scott C
Ann Thorac Surg
. 1979 Jul;
28(1):69-72.
PMID: 454047
Activated coagulation time (ACT) for protamine reversal was monitored in 28 consecutive patients (Group 1) and a standard heparin-protamine protocol was used for an earlier series of 28 patients (Group...